New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease

The effective and fast reduction of circulating low-density lipoprotein cholesterol (LDL-C) is a cornerstone for secondary prevention of atherosclerotic disease progression. Despite the substantial lipid-lowering effects of the established treatment option with statins and ezetimibe, a significant p...

Descripción completa

Detalles Bibliográficos
Autores principales: Burger, Achim Leo, Pogran, Edita, Muthspiel, Marie, Kaufmann, Christoph Clemens, Jäger, Bernhard, Huber, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138506/
https://www.ncbi.nlm.nih.gov/pubmed/35625707
http://dx.doi.org/10.3390/biomedicines10050970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138506/
https://www.ncbi.nlm.nih.gov/pubmed/35625707
http://dx.doi.org/10.3390/biomedicines10050970

Ejemplares similares